MktsMarkets

Gilead Sciences, Inc.
NASDAQ: GILDKey statistics
GILD News
Stories mentioning GILD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 6,960,000 | 7,925,000 | 7,769,000 | 7,082,000 | 6,667,000 | 7,569,000 | 7,545,000 | 6,954,000 |
| Cost of Goods Sold | 1,445,000 | 1,624,000 | 1,569,000 | 1,501,000 | 1,540,000 | 1,581,000 | 1,574,000 | 1,544,000 |
| Gross Profit | 5,515,000 | 6,301,000 | 6,200,000 | 5,581,000 | 5,127,000 | 5,988,000 | 5,971,000 | 5,410,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 1,451,000 | 1,794,000 | 1,357,000 | 1,365,000 | 1,258,000 | 1,906,000 | 1,433,000 | 1,377,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 2,586,000 | 1,984,000 | 3,327,000 | 2,474,000 | 2,237,000 | 2,452,000 | 888,000 | 2,644,000 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (2,000) | 2,000 | (1,000) | (6,000) | 4,000 | 5,000 | (4,000) | 1,000 |
| Pretax Income | 2,580,000 | 2,077,000 | 3,641,000 | 2,429,000 | 1,649,000 | 2,167,000 | 956,000 | 2,053,000 |
| Tax Provision | 559,000 | (105,000) | 589,000 | 468,000 | 334,000 | 385,000 | (297,000) | 438,000 |
| Net Income (Loss) | 2,021,000 | 2,183,000 | 3,052,000 | 1,960,000 | 1,315,000 | 1,783,000 | 1,253,000 | 1,614,000 |
| Earnings Per Share (Basic) | 1.63 | 1.75 | 2.46 | 1.57 | 1.06 | 1.43 | 1.00 | 1.29 |
| Earnings Per Share (Diluted) | 1.61 | 1.74 | 2.43 | 1.56 | 1.04 | 1.42 | 1.00 | 1.29 |
| Weighted Average Shares Outstanding (Basic) | 1,242,000 | 1,244,000 | 1,243,000 | 1,245,000 | 1,246,000 | 1,247,000 | 1,247,000 | 1,247,000 |
| Weighted Average Shares Outstanding (Diluted) | 1,254,000 | 1,255,000 | 1,254,000 | 1,255,000 | 1,259,000 | 1,255,000 | 1,254,000 | 1,251,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GILD
Gilead Sciences, Inc. (NASDAQ: GILD) is a stock listed on the Nasdaq Stock Market under the ticker symbol GILD. It last traded at $169.73 (Nov 11, 2026, 4:00 PM ET), down 0.7% on the day. That gives Gilead Sciences a market capitalisation of $210.5B.
Over the past 52 weeks GILD has traded between $116.88 and $176.58.
Revenue for the quarter ended Mar 31, 2026 was $7.0B; net income $2.0B. Revenue was up 4.4% from $6.7B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $7.0B | $2.0B | 29.0% |
| Dec 31, 2025 | $7.9B | $2.2B | 27.5% |
| Sep 30, 2025 | $7.8B | $3.1B | 39.3% |
| Jun 30, 2025 | $7.1B | $2.0B | 27.7% |
From Gilead Sciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…